Pacira BioSciences: Not Done Yet Despite Devastating Share Price Losses

Company Overview - Pacira BioSciences, Inc. (NASDAQ: PCRX) stock is currently trading at $18, a significant decline from its peak of $115 per share in 2015 and over $75 per share in March 2022 [2]. Stock Performance - The stock has experienced a near-constant decline, reaching a low of approximately $13 in mid-August [2]. Investment Insights - The investing group Haggerston BioHealth provides insights for both novice and experienced biotech investors, including catalysts to watch for, buy and sell ratings, product sales forecasts, and integrated financial statements [2].